I henhold til værdipapirhandelslovens § 28a skal ChemoMetec A/S indberette oplysninger om ledende medarbejderes og disses nærtstående transaktioner med ChemoMetec A/S aktier.
Recommended Reading
-
Trading statement for Q3 2025/26 (1 January – 31 March 2026) Growth in revenue and operating profit ChemoMetec’s revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK...
Read More -
ANNOUNCEMENT NO. 307 4 May 2026 Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance To ensure continued compliance with the applicable accounting...
Read More